These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9636479)
1. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Schütz E; Shipkova M; Armstrong VW; Niedmann PD; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M Transplant Proc; 1998 Jun; 30(4):1185-7. PubMed ID: 9636479 [No Abstract] [Full Text] [Related]
2. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite. Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Wieland E; Oellerich M Transplant Proc; 1999; 31(1-2):1135-7. PubMed ID: 10083508 [No Abstract] [Full Text] [Related]
3. Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation. Mourad M; Chaib-Eddour D; Malaise J; König J; Squifflet JP; Wallemacq PE Transplant Proc; 2000 Mar; 32(2):404-6. PubMed ID: 10715456 [No Abstract] [Full Text] [Related]
4. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified? Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157 [No Abstract] [Full Text] [Related]
5. How to handle mycophenolate mofetil in combination with tacrolimus? Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309 [No Abstract] [Full Text] [Related]
6. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation. Wollenberg K; Krumme B; Pisarski P; Schollmeyer P; Kirste G Transplant Proc; 1998 Dec; 30(8):4090-1. PubMed ID: 9865307 [No Abstract] [Full Text] [Related]
8. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Gregoor PJ; de Sévaux RG; Hené RJ; Hesse CJ; Hilbrands LB; Vos P; van Gelder T; Hoitsma AJ; Weimar W Transplantation; 1999 Nov; 68(10):1603-6. PubMed ID: 10589962 [TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation. Brunet M; Oppenheimer F; Martorell J; Vilardell J; Carreño MC; Carrillo M; Corbella J Transplant Proc; 1999 Sep; 31(6):2275-6. PubMed ID: 10500574 [No Abstract] [Full Text] [Related]
10. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid. Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429 [No Abstract] [Full Text] [Related]
11. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients. Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482 [No Abstract] [Full Text] [Related]
12. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid. Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678 [No Abstract] [Full Text] [Related]
13. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2]. Royer B; Davani S; Bérard M; Kantelip JP; Muret P Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001 [TBL] [Abstract][Full Text] [Related]
14. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients. Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679 [No Abstract] [Full Text] [Related]
16. Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation. Zanker B; Sohr B; Eder M; Frohmann E; Land W Transplant Proc; 1999; 31(1-2):1167. PubMed ID: 10083521 [No Abstract] [Full Text] [Related]
17. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique. Martiny D; Macours P; Cotton F; Thiry P; Gulbis B Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899 [TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation. Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219 [No Abstract] [Full Text] [Related]
20. Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients. Schütz E; Armstrong VW; Shipkova M; Weber L; Niedmann PD; Lammersdorf T; Wiesel M; Mandelbaum A; Zimmerhackl LB; Mehls O; Tönshoff B; Oellerich M Transplant Proc; 1998 Jun; 30(4):1182-4. PubMed ID: 9636478 [No Abstract] [Full Text] [Related] [Next] [New Search]